Skip to main content

Table 2 Evaluation of average  % parasitaemia and  % suppression of parasitaemia in Peters’ test

From: In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives

Groups

Compounds

Dose (mg/kg)

Average  % parasitaemia ± SD (Day 4)

% Suppression of parasitaemia (Day 4)

Average  % parasitaemia ± SD (Day 8)

P-value

Oil

5.33 ± 2.12

10.68 ± 1.11

DMSO

7.41 ± 1.65

13.16 ± 1.47

CQ

25

0

100

0

1

1a

125

2.44 ± 1.56

61.69

3.20 ± 1.46

 

1b

62

3.37 ± 2.39

47.10

6.85 ± 0.45

< 0.05

1c

31

5.86 ± 1.06

8.01

8.89 ± 2.25

 

2

2a

125

0.06 ± 0.17

99.09

2.75 ± 0.84

 

2b

62

2.92 ± 2.79

54.16

4.85 ± 1.30

< 0.05

2c

31

6.02 ± 1.79

5.49

9.30 ± 2.75

 

3

3a

125

2.13 ± 1.75

66.50

2.55 ± 0.42

 

3b

62

3.68 ± 0.76

42.26

8.18 ± 0.97

< 0.05

3c

31

1.35 ± 1.86

78.74

7.25 ± 1.07

 

4

4a

125

1.95 ± 0.44

69.39

4.26 ± 2.17

 

4b

62

3.63 ± 2.51

43.01

7.54 ± 2.52

< 0.05

4c

31

5.07 ± 2.54

20.41

9.96 ± 2.27

 
  1. The in vivo activities were evaluated against Plasmodium berghei
  2. Italic values indicate the best compounds based on Peters’ test
  3. SD standard deviation